Bank7 Corp.
NASDAQ:BSVNBanks - Regional
+$0.18 today
- Market cap
- $612.56M
- Beta
- 0.94
- P/E (TTM)
- 9.7
- EPS (TTM)
- $4.71
- Dividend yield
- 2.35%
Volume 0.04M
Average 0.01M
BSVN Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
Bank7 Corp.NASDAQ: BSVN
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 2.7% from a year ago
Cash & equivalents stood at $246.7M at the end of Q1 FY2026, down 2.7% from a year earlier and up 0.8% from the prior quarter. Over 3 fiscal years it compounded at +28.8% a year.
Context
- Cash & equivalents amounted to 12.7% of total assets at the end of Q1 FY2026, down 1.5 pp from a year earlier.
- Cash & equivalents increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -2.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 244.64M USD
- Year-over-year change
- +1.5%
- 4-year CAGR
- +5.4%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 244.64M | +1.5% |
| FY2024 | 2024-12-31 | 240.92M | +21.2% |
| FY2023 | 2023-12-31 | 198.72M | +73.4% |
| FY2022 | 2022-12-31 | 114.59M | -42.3% |
| FY2021 | 2021-12-31 | 198.6M | — |
Cash & Equivalents vs competitors
How BSVN compares with its peers on the latest reported figures
- BSVN's Mar 2026 cash & equivalents of $246.7M is the highest of the 11 companies compared; the peer median is $148.11M.
- Its year-over-year change of -2.7% is the 5th highest of 11, against a peer median of -7.6%.
- Cash & equivalents amounts to 12.7% of total assets for BSVN, versus a peer median of 4.3%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $246.7M | -2.7% | +28.8% | 12.7% | |
| Mar 2026 | $223.48M | +102.0% | +17.3% | 6.3% | |
| Mar 2026 | $220.24M | +4.6% | +136.2% | 5.5% | |
| Mar 2026 | $208.9M | -28.5% | -13.3% | 6.2% | |
| Mar 2026 | $156.37M | -2.1% | +20.7% | 4.2% | |
| Mar 2026 | $155.55M | -6.5% | -21.2% | 7.7% | |
| Mar 2026 | $140.68M | -10.5% | +36.1% | 4.4% | |
| Mar 2026 | $137.13M | -19.6% | -33.1% | 3.2% | |
| Mar 2026 | $83.53M | -8.6% | +20.5% | 1.9% | |
| Mar 2026 | $25.1M | -2.6% | -1.7% | 2.4% | |
| Mar 2026 | $9.44M | -92.4% | +16.1% | 0.4% | |
| Peer median (excluding BSVN) | $148.11M | -7.6% | +16.7% | 4.3% | |
Competitors are the stored peer set for BSVN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 198.6M | 114.59M | 198.72M | 240.92M | 244.64M |
| Short-term Investments | 84.81M | 173.17M | 139.69M | 32.22M | 10.46M |
| Net Receivables | 10.52M | 16.44M | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 43.56M |
| Total Current Assets | 293.93M | 304.19M | 338.41M | 273.14M | 298.65M |
| Property, Plant & Equipment (Net) | 17.26M | 13.11M | 14.94M | 18.14M | 21.88M |
| Goodwill | 8.48M | 8.6M | 8.46M | 8.46M | 11.21M |
| Intangible Assets | 1.64M | 1.34M | 1.03M | 878K | 752K |
| Long-term Investments | 1.02B | 1.26B | 1.34B | 1.38B | 55.18M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 9.49M | 0 | 65.68M | 58.45M | (55.18M) |
| Total Non-current Assets | 1.06B | 1.28B | 1.43B | 1.47B | 33.84M |
| Total Assets | 1.35B | 1.58B | 1.77B | 1.74B | 1.96B |
| Account Payables | 5.67M | 9.72M | 0 | 0 | 0 |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 0 | 1.05M | 302K | 77K | 594K |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.22B | 1.43B | 1.59B | 1.52B | 594K |
| Total Current Liabilities | 1.22B | 1.44B | 1.59B | 1.52B | 594K |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | (1.05M) | 9.65M | 11.12M | 1.71B |
| Total Non-current Liabilities | 0 | (1.05M) | 9.65M | 11.12M | 1.71B |
| Total Liabilities | 1.22B | 1.44B | 1.6B | 1.53B | 1.71B |
| Common Stock | 91K | 91K | 92K | 94K | 95K |
| Retained Earnings | 33.15M | 58.05M | 78.96M | 116.28M | 149.71M |
| Accumulated OCI | 144K | (9.3M) | (6.15M) | (4.97M) | (2.55M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 127.41M | 144.1M | 170.33M | 213.21M | 251M |
| Total Debt | 0 | 0 | 0 | 0 | 0 |
| Net Debt | (198.6M) | (114.59M) | (198.72M) | (240.92M) | (244.64M) |
Bank7 Corp.
NASDAQ:BSVN
Intrinsic Alpha fair value
Locked
Current Price
$57.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.